ReviR Therapeutics raised $30M in a Series A financing led by Lapam Capital to advance its proprietary oral genetic medicines for multiple CNS disorders
Amount Raised
$30 Million
Round Type
Series A
San FranciscoBiotechnologyFinancial ServicesLending And InvestmentsInvestors
Description
ReviR Therapeutics announced the successful completion of a $30 million Series A financing, bringing the total raised so far to $54M. The financing was led by Lapam Capital with support from existing investors CDH Investments, 5Y Capital, and Yael Capital, as well as new participants XtalPi and the Charcot-Marie Tooth Research Foundation (CMTRF). The funds will be used to further augment ReviR's AI-driven drug discovery VoyageR platform and to support clinical development of treatments for Huntington's disease (HD), Charcot-Marie-Tooth disease (CMT), amyotrophic lateral sclerosis (ALS), and other neurological disorders.
Quick answer
Revi R Therapeutics raised $30 Million in a Series A round, dated July 26, 2024. Investors: Xtal Pi (2228.Hk), Charcot Marie Tooth Research Foundation (Cmtrf), Yael Capital, 5 Y Capital, CDH Investments and Lapam Capital. Revi R Therapeutics is based in San Francisco, California, United States.
- How much did Revi R Therapeutics raise?
- Revi R Therapeutics raised $30 Million in a Series A round on July 26, 2024.
- Who invested in Revi R Therapeutics?
- Xtal Pi (2228.Hk), Charcot Marie Tooth Research Foundation (Cmtrf), Yael Capital, 5 Y Capital, CDH Investments and Lapam Capital are named as investors in this round.
- Where is Revi R Therapeutics based and how big is it?
- Revi R Therapeutics is based in San Francisco, California, United States.
- Who are the decision-makers at Revi R Therapeutics?
- Fundz holds 1 contact at Revi R Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Financial Services and Lending And Investments around the same time
Companies in the same sectors as Revi R Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Ensysce Biosciences raised $5.1M on August 29, 2024.
- Monetary Metals raised $16M on August 8, 2024.
- Slope raised $65M (Debt Financing) on July 17, 2024.
- Route 92 Medical raised $50M on June 28, 2024.
- Twenty7tec raised $22M (Series A) on September 9, 2024.
- Somite raised $4.8M (Pre-Seed) on September 9, 2024.
Who to call at Revi R Therapeutics, and when
A new round usually means Revi R Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Revi R Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Revi R Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Revi R Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Revi R Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansRevi R Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.